Role of endothelial progenitor cells in vascular development, homestatic maintenance of blood vessels and in injury-mediated reparative response

Q1 Biochemistry, Genetics and Molecular Biology
U. Testa, G. Castelli, E. Pelosi
{"title":"Role of endothelial progenitor cells in vascular development, homestatic maintenance of blood vessels and in injury-mediated reparative response","authors":"U. Testa, G. Castelli, E. Pelosi","doi":"10.21037/sci.2020.03.02","DOIUrl":null,"url":null,"abstract":"The blood vasculature is a closed circulatory system formed by arteries, veins and capillaries; the inner layer of these vessels is formed by a single layer of endothelial cells. Endothelial cells are specialized according to the specific needs of the tissues that they supply. The vascular system derives from the differentiation of mesodermal stem cells into angioblasts, embryonic endothelial progenitors. Endothelial progenitor cells (EPCs) are also present in adult life. Two types of EPCs have been reported: one of nonhematopoietic origin, endothelial colony forming cell (ECFC) able to generate endothelial cells, resident in vessel wall and present at low levels in peripheral blood and directly participating to the regeneration of endothelium following injury or ischemic damage; another of hematopoietic origin, called myeloid angiogenic cells (MACs), resident in bone marrow, generating monocytic cells, supporting angiogenesis through paracrine mechanisms. ECFCs play a role in reparative processes. ECFCs display a hierarchy of clonal proliferative potential and display a pronounced postnatal vascularization ability in vivo. For these properties, ECFCs represent a promising cell source for revascularization of damaged tissue. The use of ECFC for therapeutic use is still an embryonic field, but the therapeutic use of these cells holds great promise for the future.","PeriodicalId":21938,"journal":{"name":"Stem cell investigation","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem cell investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/sci.2020.03.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

The blood vasculature is a closed circulatory system formed by arteries, veins and capillaries; the inner layer of these vessels is formed by a single layer of endothelial cells. Endothelial cells are specialized according to the specific needs of the tissues that they supply. The vascular system derives from the differentiation of mesodermal stem cells into angioblasts, embryonic endothelial progenitors. Endothelial progenitor cells (EPCs) are also present in adult life. Two types of EPCs have been reported: one of nonhematopoietic origin, endothelial colony forming cell (ECFC) able to generate endothelial cells, resident in vessel wall and present at low levels in peripheral blood and directly participating to the regeneration of endothelium following injury or ischemic damage; another of hematopoietic origin, called myeloid angiogenic cells (MACs), resident in bone marrow, generating monocytic cells, supporting angiogenesis through paracrine mechanisms. ECFCs play a role in reparative processes. ECFCs display a hierarchy of clonal proliferative potential and display a pronounced postnatal vascularization ability in vivo. For these properties, ECFCs represent a promising cell source for revascularization of damaged tissue. The use of ECFC for therapeutic use is still an embryonic field, but the therapeutic use of these cells holds great promise for the future.
内皮祖细胞在血管发育、血管稳态维持和损伤介导的修复反应中的作用
血管系统是由动脉、静脉和毛细血管形成的封闭循环系统;这些血管的内层是由单层内皮细胞形成的。内皮细胞是根据其提供的组织的特定需求而专门化的。血管系统来源于中胚层干细胞分化为成血管细胞,即胚胎内皮祖细胞。内皮祖细胞(EPC)也存在于成人生活中。已经报道了两种类型的内皮祖细胞:一种是非造血来源的内皮集落形成细胞(ECFC),能够产生内皮细胞,驻留在血管壁中,在外周血中以低水平存在,并直接参与损伤或缺血性损伤后内皮的再生;另一种造血来源的细胞,称为骨髓血管生成细胞,存在于骨髓中,产生单核细胞,通过旁分泌机制支持血管生成。ECFC在修复过程中发挥作用。ECFC在体内表现出克隆增殖潜力的层次,并表现出显著的产后血管形成能力。对于这些特性,ECFC代表了一种很有前途的细胞来源,用于受损组织的血运重建。ECFC用于治疗用途仍然是一个胚胎领域,但这些细胞的治疗用途对未来有很大的前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Stem cell investigation
Stem cell investigation Biochemistry, Genetics and Molecular Biology-Developmental Biology
CiteScore
5.80
自引率
0.00%
发文量
9
期刊介绍: The Stem Cell Investigation (SCI; Stem Cell Investig; Online ISSN: 2313-0792) is a free access, peer-reviewed online journal covering basic, translational, and clinical research on all aspects of stem cells. It publishes original research articles and reviews on embryonic stem cells, induced pluripotent stem cells, adult tissue-specific stem/progenitor cells, cancer stem like cells, stem cell niche, stem cell technology, stem cell based drug discovery, and regenerative medicine. Stem Cell Investigation is indexed in PubMed/PMC since April, 2016.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信